Research progress in biologic markers for prostate cancer
CSTR:
Author:
Affiliation:

(1. Central Laboratory of Molecular Medicine Research Center,Jiaxing 314001, Zhejiang Province, China;3. Department of Urology Surgery,Jiaxing 314001, Zhejiang Province, China;4.Department of Radiology,Jiaxing 314001, Zhejiang Province, China;5.Department of Ultrasound, Jiaxing Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medicial University, Jiaxing 314001, Zhejiang Province, China;2. Department of Urology Surgery, Jiaxing Second Hospital, Jiaxing 314001, Zhejiang Province, China;6. Jiaxing Key Laboratory of Diabetic Angiopathy, Jiaxing 314001, Zhejiang Province, China)

Clc Number:

R737.25

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    As one of the most common cancers in men, prostate cancer seriously threatens their health and safety. There are many challenges of prostate cancer in prediction, diagnosis and prognosis. Although biomarkers for the prostate cancer have shown certain clinic significance, they still have limitations when used alone. Accurate diagnosis, prevention of excessive biopsies, and construction of a diagnostic system of combined biomarkers are still trending research topics in the detection of prostate cancer. Here we analyze the cha-llenges in the detection of prostate cancer and review the research progress in biomarkers and related detection systems of prostate cancer.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 11,2020
  • Revised:
  • Adopted:
  • Online: January 22,2021
  • Published:
Article QR Code